Literature DB >> 231364

Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival.

J Aisner, S C Aisner, S Ostrow, S Govindan, K Mummert, P Wiernik.   

Abstract

The cells of oat cell carcinoma of the lung can be identified in sputum because of their characteristic morphologic appearance. The cells from oat cell carcinomas can also be identified in other body fluids but are seen there less often. Spinal fluid involvement with oat cell carcinoma has been seen very infrequently, presumably because of a poor survival rate. Aggressive systemic chemotherapy has improved survival, and meningeal involvement is now being recognized as a complication. Of 62 patients treated by aggressive chemotherapy protocols, six (10%) were found to have leptomeningeal involvement by cytologic evaluation of cerebrospinal fluid (CSF). Involvement was found 6 to 13 months after the initiation of therapy. Two of the six patients had no evidence of CNS metastases by CAT brain scan. Necropsy was performed in three of the six cases and showed excellent histologic correlation with the cytologic findings. Because of most therapeutic drugs' poor penetration into the CSF, and because the spinal cord is not routinely irradiated, cytologic examination of the CSF from patients with oat cell carcinoma is necessary when there are new neurologic signs or symptoms to ensure proper, specific therapy.

Entities:  

Mesh:

Year:  1979        PMID: 231364

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  5 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis.

Authors:  A G Pedersen; O B Paulson; C Gyldensted
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 3.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Pharmacokinetics of intraventricular administration.

Authors:  J M Collins
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Brain CT-scanning and neurological examination in small cell bronchogenic carcinoma.

Authors:  A G Pedersen; A Karle; G Boysen; K Højgaard; P Dombernowsky
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.